Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update

NEXT STORY
Aerpio Pharmaceuticals, Inc. Announces a Second Clinical Trial with Funding from MTEC to Evaluate Razuprotafib for the Prevention and Treatment of ARDS in Patients with Moderate to Severe COVID-19
PREV STORY
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mind Medicine, Inc. and Broadway Gold Mining Ltd. Announce Definitive Arrangement Agreement

author_avatar
NASDAQ Market News

TLC Reports Positive Top-Line Results from Phase I/II Clinical Trial of TLC590 for Postsurgical Pain

author_avatar
NASDAQ Market News

Tarsus Pharmaceuticals, Inc. Presents Results of Pioneering Atlas Study at ARVO 2021 Annual Meeting Demonstrating the Functional and Psychosocial Impact of Demodex Blepharitis

author_avatar
NASDAQ Market News